新光药业

300519 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

2.5B ($356.2M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

268.0M

Net Income

50.4M

Gross Margin

N/A

Op. Margin

21.4%

Net Margin

18.8%

ROE

6.1%

ROA

5.5%

D/E

0.10

Dividend Yield

N/A

EPS

0.31

Current Ratio

10.98

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 新光药业

Ticker	300519
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业